Archive of WILEX Press Releases

Selected press releases of the former years can be found here.

 2007

 2006

 2005

 2004

 2003

02 December 2003

WILEX receives patents for its anti-cancer drug candidate WX-UK1 in USA, Europe and Australia

08 October 2003

WILEX awarded third prize of European BioTechnica Award for Excellence in Biotech Business

04 September 2003

WILEX and Fox Chase Cancer Center awarded first Biotechnology Clinical Partnership Award worth $3.9 million from U.S. Department of Defense Breast Cancer Research Program

01 September 2003

Former Oxford GlycoSciences CEO and Bayer Pharmaceutical Division President elected Chairman of WILEX’s Supervisory Board

22 May 2003

WILEX receives IND Approval from FDA for its anti-Cancer drug candidate WX-UK1

15 May 2003

WILEX licenses anti-cancer antibody from VU University Medical Center Amsterdam

6 March 2003

WILEX appoints Paul Bevan as new Head of Research and Development

17 February 2003

WILEX and the San Raffaele Biomedical Science Park develop antibodies against new tumor target

 2002 and earlier